Barclays Plc - Apr 25, 2022 Form 3 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role: 10%+ Owner
Signature: Suejean Mott
Stock symbol: PYXS
Transactions as of: Apr 25, 2022
Transactions value $: $0
Form type: 3
Date filed: 4/26/2022, 01:40 PM
Previous filing: Mar 9, 2022
Next filing: Apr 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PYXS	Common Stock, par value $0.001 per share						3.48M	Apr 25, 2022	By Barclays Bank PLC
holding	PYXS	Common Stock, par value $0.001 per share						30	Apr 25, 2022	By Barclays Capital Inc.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

(a) Beneficially owned Class A ordinary shares are comprised in Units, each consisting of one class A ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if none, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 United States